FDA recall record
OXZGEN Performance 25 mg Hemp Derived CBD + Teacrine + BCAA Orange Flavored, 5 blast caps, 2.2 FL OZ
FDA classification. FDA Class I, II, and III are not the same as USDA FSIS classifications and are not a cross-agency safety score.
FDA listed a termination date of February 20, 2020. openFDA does not treat this as a live recall-status tracker.
Product described in an FDA recall
OXZGEN Performance 25 mg Hemp Derived CBD + Teacrine + BCAA Orange Flavored, 5 blast caps, 2.2 FL OZ
Reason
Yellow #6 is not declared on ingredient label. Label claim for B2 is incorrect (contains 5 mg not 10 mg as stated).
Products involved
Product descriptions are copied from the FDA recall record. They are not a current catalog and are not automatically matched to WhoMadeMyFood product pages.
OXZGEN Performance 25 mg Hemp Derived CBD + Teacrine + BCAA Orange Flavored, 5 blast caps, 2.2 FL OZ
Code information listed by FDA
10097902, 10186904, 10235905, and 10278906
Distribution and firm information
Recalling firm listed by FDA: Hall Global, LLC
Firm location listed by FDA: Southlake, TX, United States
Distribution reported by FDA: Contract Manufacturer sends products to distribution centers owned by clients or direct to client company for distribution via internet to end product user.
Product quantity listed by FDA: 1007 packages of 5 count caps
Source
Source: U.S. Food and Drug Administration (FDA), openFDA food enforcement reports.
Official FDA openFDA food enforcement record
Identifying an FDA recall record does not imply FDA endorsement of WhoMadeMyFood. Methodology.